Heart disease and cancer were again the leading causes of death in the U.S. in 2024, according to a CDC report published Sept. 10, which analyzed 99.9% of 2024 death records as of June 1, 2025. At the same time,…

Data from more than 750 hospitals indicate the most effective tool to reduce inpatient falls is sensor technology, according to a Sept. 10 report from Sg2, a Vizient company.  Fall-prevention sensor technologies, such as bed, chair and toilet alarms, can…

The Make America Healthy Again Commission, a newly created advisory body under HHS, published a report on chronic disease and children’s health Sept. 9.  The commission’s “Make Our Children Healthy Again Strategy” covers a slew of topics, including environmental chemicals,…

NYC Health + Hospitals, an 11-hospital system based in New York City, has saved nearly $250 million through strategies to reduce nurse turnover costs and reliance on travel staff.  In 2024, the health system saved more than $150 million by…

Ascension has reached its highest nurse retention rate in five years — 81.96% — aided by its employee feedback tool Always On Listening, or AOL.  The tool helps address the “pebbles” in people’s shoes, according to Rob Rose, DNP, RN,…

Around the time when West Texas declared its measles outbreak over, the CDC published a measles assessment tool for infection control in healthcare settings.  The assessment, rolled out Aug. 18, is intended to aid health departments and healthcare facilities in…

Massachusetts vaccinates the most out of any state, according to a WalletHub report published Sept. 9. To determine which states vaccinate most, the financial services site analyzed data across 16 metrics, which were grouped into three key areas: immunization rates…

Hospital readmissions are tough to track as patients increasingly opt for other hospitals when they’re not satisfied with their care. Vizient developed the CMS Qualified Entity Public Report last month and Kaufman Hall highlighted findings in a Sept. 5 article.…

Mass General Brigham, based in Somerville, Mass., and eGenesis have received FDA approval for a clinical trial testing genetically engineered pig kidneys.  The trial will evaluate the safety, tolerability and efficacy of EGEN-2784, a genetically engineered pig kidney, after 24…

Key Takeaways Genetic testing is rapidly moving genomics from a niche specialty to becoming more integrated into mainstream clinical practice. Once deployed primarily to diagnose rare and inherited conditions after initial clinical evaluations, genetic insights are now shaping real-time treatment…